Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel J Grothe

Showing results (71-80 of 157) with videos related to

Pageof 16
Sort By:
JAMA Neurology|August 14, 2023
Increased Medial Temporal Tau Positron Emission Tomography Uptake in the Absence of Amyloid-β PositivityAlejandro Costoya-Sánchez, Alexis Moscoso, Jesús Silva-Rodríguez, et al.
Schizophrenia Bulletin|August 22, 2023
Basal-Forebrain Cholinergic Nuclei Alterations are Associated With Medication and Cognitive Deficits Across the Schizophrenia SpectrumJulia Schulz, Felix Brandl, Michel J Grothe, et al.
Neurobiology of Disease|March 8, 2020
Longitudinal degeneration of the basal forebrain predicts subsequent dementia in Parkinson's diseaseJoana B Pereira, Sara Hall, Mattis Jalakas, et al.
Brain Communications|December 20, 2024
Divergent neurodegenerative patterns: Comparison of [<sup>18</sup>F] fluorodeoxyglucose-PET- and MRI-based Alzheimer's disease subtypesSophia H Wheatley, Rosaleena Mohanty, Konstantinos Poulakis, et al.
Human Brain Mapping|January 31, 2019
Effective connectivity in the default mode network is distinctively disrupted in Alzheimer's disease-A simultaneous resting-state FDG-PET/fMRI studyMartin Scherr, Lukas Utz, Masoud Tahmasian, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 28, 2022
CSF biomarkers and plasma p-tau181 as predictors of longitudinal tau accumulation: Implications for clinical trial designAlexis Moscoso, Thomas K Karikari, Michel J Grothe, et al.
Neurology|July 16, 2021
Associations of Fully Automated CSF and Novel Plasma Biomarkers With Alzheimer Disease Neuropathology at AutopsyMichel J Grothe, Alexis Moscoso, Nicholas J Ashton, et al.
Clinical Nuclear Medicine|February 29, 2020
FDG Uptake in the Basal Forebrain as Measured by Digital High-Resolution PET Is a Promising Marker of Basal Forebrain Degeneration in the Lewy Body Disease Spectrum: A Pilot StudyCansu Özden, Lars Frings, Ivayla Apostolova, et al.
Neuroreport|June 17, 2016
Hippocampal volume and integrity as predictors of cognitive decline in intact elderlyDavide Bruno, Adam Ciarleglio, Michel J Grothe, et al.
Neuroimage. Clinical|December 18, 2018
Subregional volume reduction of the cholinergic forebrain in subjective cognitive decline (SCD)Lukas Scheef, Michel J Grothe, Alexander Koppara, et al.
Pageof 16

Showing results (71-80 of 157) with videos related to

Sort By:
Pageof 16
JAMA Neurology|August 14, 2023
Increased Medial Temporal Tau Positron Emission Tomography Uptake in the Absence of Amyloid-β PositivityAlejandro Costoya-Sánchez, Alexis Moscoso, Jesús Silva-Rodríguez, et al.
Schizophrenia Bulletin|August 22, 2023
Basal-Forebrain Cholinergic Nuclei Alterations are Associated With Medication and Cognitive Deficits Across the Schizophrenia SpectrumJulia Schulz, Felix Brandl, Michel J Grothe, et al.
Neurobiology of Disease|March 8, 2020
Longitudinal degeneration of the basal forebrain predicts subsequent dementia in Parkinson's diseaseJoana B Pereira, Sara Hall, Mattis Jalakas, et al.
Brain Communications|December 20, 2024
Divergent neurodegenerative patterns: Comparison of [<sup>18</sup>F] fluorodeoxyglucose-PET- and MRI-based Alzheimer's disease subtypesSophia H Wheatley, Rosaleena Mohanty, Konstantinos Poulakis, et al.
Human Brain Mapping|January 31, 2019
Effective connectivity in the default mode network is distinctively disrupted in Alzheimer's disease-A simultaneous resting-state FDG-PET/fMRI studyMartin Scherr, Lukas Utz, Masoud Tahmasian, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 28, 2022
CSF biomarkers and plasma p-tau181 as predictors of longitudinal tau accumulation: Implications for clinical trial designAlexis Moscoso, Thomas K Karikari, Michel J Grothe, et al.
Neurology|July 16, 2021
Associations of Fully Automated CSF and Novel Plasma Biomarkers With Alzheimer Disease Neuropathology at AutopsyMichel J Grothe, Alexis Moscoso, Nicholas J Ashton, et al.
Clinical Nuclear Medicine|February 29, 2020
FDG Uptake in the Basal Forebrain as Measured by Digital High-Resolution PET Is a Promising Marker of Basal Forebrain Degeneration in the Lewy Body Disease Spectrum: A Pilot StudyCansu Özden, Lars Frings, Ivayla Apostolova, et al.
Neuroreport|June 17, 2016
Hippocampal volume and integrity as predictors of cognitive decline in intact elderlyDavide Bruno, Adam Ciarleglio, Michel J Grothe, et al.
Neuroimage. Clinical|December 18, 2018
Subregional volume reduction of the cholinergic forebrain in subjective cognitive decline (SCD)Lukas Scheef, Michel J Grothe, Alexander Koppara, et al.
Pageof 16